Probiotics for IBS and IBD: What's the Harm? episode artwork

EPISODE · Jun 25, 2009 · 13 MIN

Probiotics for IBS and IBD: What's the Harm?

from GI Insights

Host: Mark DeLegge, MD Guest: Charles Bernstein, MD Probiotics are becoming increasingly popular, but is there any substantial evidence supporting the efficacy of probiotics for irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD)? Are there any potential risks to IBS and IBD patients using probiotic therapy? Which probiotic strains might be most beneficial, and what dosage is optimal? Dr. Charles Bernstein, director of the University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre, explores these and other questions, and suggests physicians might want to be cautious when considering probiotic therapy for their patients. Hosted by Dr. Mark DeLegge.

Episode metadata supplied by the publisher feed · Published Jun 25, 2009

Embed this episode

NOW PLAYING

Probiotics for IBS and IBD: What's the Harm?

0:00 13:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of GI Insights?

This episode is 13 minutes long.

When was this GI Insights episode published?

This episode was published on June 25, 2009.

Can I download this GI Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!